There are 2789 resources available
1176P - Neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in patients with potentially resectable NSCLC: An open-label, single-arm, phase II trial
Presenter: Xinsheng Zhu
Session: ePoster Display
1177P - Real-world treatment patterns and outcomes in stage III non-small cell lung cancer (NSCLC): Middle East and Africa (MEA)-KINDLE study
Presenter: Abdul Rahman Jazieh
Session: ePoster Display
1205P - Treatment sequencing and duration of subsequent tyrosine kinase inhibitors in ALK+ non-small cell lung cancer patients treated with brigatinib in the US
Presenter: Mohammad Jahanzeb
Session: ePoster Display
1206P - UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)
Presenter: Jair Bar
Session: ePoster Display
1181P - The impact of dosimetric parameters on pneumonitis in patients with stage III non-small cell lung cancer during maintenance treatment with durvalumab after chemoradiotherapy
Presenter: Martina Vrankar
Session: ePoster Display
1182P - Next generation sequencing reveals the genetic landscape of PTPN11 in Chinese lung cancer patients
Presenter: Jun Zhang
Session: ePoster Display
1184P - Necroptosis establishes an inflammatory tumor immune microenvironment acting as tumor suppressor in lung adenocarcinoma
Presenter: Fabian Allmendinger
Session: ePoster Display
1185P - Induction immunotherapy in resectable non-small cell lung cancer harboring driver mutations: A multi-center retrospective study
Presenter: Chao Zhang
Session: ePoster Display
1086P - IBI310 alone or in combination with sintilimab for advanced melanoma: Updated results of a phase Ia/Ib study
Presenter: BIN LIAN
Session: ePoster Display